This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Does Late Lumen Loss Predict Clinical Restenosis in Drug-eluting Stents?
* Case Presentation
* Clinical Restenosis in the DES Era
* Late Loss and Restenosis
* LL Predicts Binary Angio Restenosis (BAR) Rate
* Monotonic Relationship of Mean to SD
* No Evidence for a Late Loss Threshold
* Monotonic LL/BAR Relationship
* Case-Mix Dependence: TLR SIRIUS Multivariable Model
* No Evidence for a Late Loss Threshold
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest, Laura Mauri, MD, has nothing to disclose regarding this CME activity.
|
|